Dual inflammation in schizophrenia infected with COVID-19: Impact on cognitive function
This study found that schizophrenia patients with COVID-19 suggested dual inflammation, and cognitive function were impaired under dual inflammation. The cognitive impairment could be reversible in the long-term of recovery of inflammation.
Authors
- Peng Wang (ORCID: https://orcid.org/0000-0002-8838-682X)
- Mingqia Wang (ORCID: https://orcid.org/0000-0002-5315-6389)
- Qi Zhou (ORCID: https://orcid.org/0000-0002-4754-4764)
- Zhuokai Zhang
- Xuan Dong (ORCID: https://orcid.org/0000-0002-5853-2136)
- Jiayi Li (ORCID: https://orcid.org/0000-0001-6888-0380)
- Jiahui Zhu
- Yuan Liu (ORCID: https://orcid.org/0000-0001-9452-0442)
- Chuan Shi (ORCID: https://orcid.org/0000-0002-2627-1189)
- Jiamin Shao
- Gangming Cheng
Institutions
- Capital Medical University (CN)
- Peking University (CN)
- Nanjing Brain Hospital (CN)
- Beijing Anding Hospital (CN)
- Peking University Sixth Hospital (CN)
- Huazhong University of Science and Technology (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Brain Behavior & Immunity - Health
- Published
- 2025-04-26
- DOI
- https://doi.org/10.1016/j.bbih.2025.100997
- Primary Topic
- Tryptophan and brain disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China